phlorhizin has been researched along with Diabetic Glomerulosclerosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Mao, X; Ran, Z; Song, Z; Wang, L; Xin, J; Yao, L; Zhang, M; Zhang, Y | 1 |
| Akamine, T; Kawanami, D; Matoba, K; Nagai, Y; Sango, K; Takeda, Y; Utsunomiya, K; Yokota, T | 1 |
| Chen, LJ; Cheng, JT; Cheng, MF; Hsu, CT; Wang, MC | 1 |
| Brouwers, B; Cauwelier, EJG; Creemers, JWM; Declercq, J; Ectors, N; Lerut, E; Pruniau, VPEG; Schuit, F | 1 |
| Kakimoto, K; Katsuda, Y; Kemmochi, Y; Kume, S; Mera, Y; Motohashi, Y; Ohta, T; Sasase, T; Tadaki, H; Toyoda, K | 1 |
| Fasching, A; Franzén, S; O'Neill, J; Palm, F; Patinha, D; Pihl, L | 1 |
| Barac-Nieto, M; Francis, I; Malatiali, S | 1 |
| Mather, A; Pollock, C | 1 |
| Chen, LJ; Cheng, JT; Cheng, MF | 1 |
| Anhê, GF; Bordin, S; Freitas, HS; Machado, UF; Melo, KF; Okamoto, MM; Oliveira-Souza, M | 1 |
2 review(s) available for phlorhizin and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Phlorhizin; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
Renal glucose transporters: novel targets for hyperglycemia management.
Topics: Animals; Biological Availability; Biological Transport; Diabetic Nephropathies; Glomerular Filtration Rate; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Kidney; Phlorhizin; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2010 |
8 other study(ies) available for phlorhizin and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in db/db mice and high glucose-treated HK-2 cells.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Cells, Cultured; Chalcones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Humans; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phlorhizin; Signal Transduction; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Decrease of FGF receptor (FGFR) and interstitial fibrosis in the kidney of streptozotocin-induced diabetic rats.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dogs; Fibroblast Growth Factor-23; Fibrosis; Glucuronidase; Hyperglycemia; Insulin; Kidney; Kidney Tubules; Klotho Proteins; Madin Darby Canine Kidney Cells; Male; Mice; Phlorhizin; Rats; Rats, Wistar; Receptors, Fibroblast Growth Factor; Superoxides | 2014 |
Phlorizin pretreatment reduces acute renal toxicity in a mouse model for diabetic nephropathy.
Topics: Animals; Antibiotics, Antineoplastic; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Insulin-Secreting Cells; Kidney; Male; Mice; Phlorhizin; Sodium-Glucose Transporter 1; Streptozocin | 2013 |
Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin.
Topics: Albuminuria; Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Models, Animal; Female; Hyperglycemia; Kidney Tubules; Phlorhizin; Rats, Inbred Strains; Rats, Sprague-Dawley; Sodium-Glucose Transport Proteins | 2015 |
Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats.
Topics: Anesthesia; Animals; Arterial Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypoxia; Kidney Cortex; Kidney Medulla; Male; Oxygen Consumption; Phlorhizin; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Glucose Transport Proteins; Urodynamics | 2015 |
Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomerular Filtration Rate; Hypertrophy; Kidney Glomerulus; Male; Organ Size; Phlorhizin; Proteinuria; Rats; Rats, Inbred F344 | 2008 |
Decrease of Klotho in the kidney of streptozotocin-induced diabetic rats.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Animals; Antioxidants; Blood Glucose; Blood Urea Nitrogen; Cell Line; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dogs; Glucose; Glucuronidase; Insulin; Kidney; Kidney Tubules; Klotho Proteins; Male; Phlorhizin; Rats; Rats, Wistar; Reactive Oxygen Species | 2010 |
Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Electrophoretic Mobility Shift Assay; Hepatocyte Nuclear Factor 1-alpha; Hyperglycemia; Hypoglycemic Agents; Immunoprecipitation; Insulin; Kidney; Male; Phlorhizin; Rats; Rats, Wistar; RNA, Messenger; Sodium-Glucose Transporter 2 | 2008 |